Tai Sandi See Lexeo Therapeutics, Inc. (LXEO) insider trading activity

Shares Held (Direct Ownership) 65.5K

11.24% 3M change

n/a 12M change

Total Value Held N/A

Tai Sandi See Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2025	SELL Open market or private sale	$3,578 $9.27 p/Share	386 Reduced 0.59%	65,476 Common Stock
Oct 17 2025	SELL Open market or private sale	$35,964 $9.25 p/Share	3,888 Reduced 5.57%	65,862 Common Stock
Oct 15 2025	BUY Grant, award, or other acquisition	-	10,890 Added 13.5%	69,750 Common Stock
Aug 18 2025	SELL Open market or private sale	$1,783 $4.67 p/Share	382 Reduced 0.64%	58,860 Common Stock
May 16 2025	SELL Open market or private sale	$1,016 $2.77 p/Share	367 Reduced 0.62%	59,242 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	$14,929 $2.61 p/Share	5,720 Added 8.76%	59,609 Common Stock
Feb 19 2025	SELL Open market or private sale	$6,553 $4.41 p/Share	1,486 Reduced 2.68%	53,889 Common Stock

Jan 07 2025	BUY Grant, award, or other acquisition	-	38,750 Added 41.17%	55,375 Common Stock

TSS

Chief Development Officer

New York, NY

Receive a notification when an Institution or Guru buys or sells LXEO shares.

Notify only if

Value

Get notified when an Lexeo Therapeutics, Inc. insider buys or sells LXEO shares.

Notify only if

Operation

Value

Type

Receive news related to Lexeo Therapeutics, Inc.